Condition: Nasal Obstruction · Sponsor: Ohio State University
About 13% of US adults, some 30 million people, suffer from nasal sinus disease. Although nasal obstruction and smell loss are two of the major symptoms of the disease that are crucial to disease management, currently there is a lack of clinical tools to effectively evaluate the mechanisms contributing to these symptoms. The proposed study aims to develop novel clinical tools to better evaluate and relieve patients' nasal obstructive symptoms and to enable patients and clinicians to make more informed, personalized decisions regarding treatment strategy.
This description comes directly from the study's public registry record.
Veronica Formanek, BS · 630-501-8168 · Veronica.Formanek@osumc.edu
Beth Miles-Markley, MS · 614-366-9244 · Beth.Miles-Markley@osumc.edu
Always discuss trial participation with your own doctor first.
| Eye and Ear Institute, 915 Olentangy River Road, ENT, Suite 4000 | Columbus, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05920330